THE Pharmaceutical Society of Australia (PSA) has released updated Guidelines for pharmacists providing smoking cessation support, coinciding with legislative changes starting 01 Oct.
The guidelines clarify the legal, professional, and ethical standards for managing nicotine dependence, including vaping products.
PSA Chief Executive Officer Adjunct A/Prof Steve Morris highlighted the importance of the updated criteria, which will help pharmacists navigate the evolving regulatory environment.
"The updated guidelines are essential for pharmacists offering nicotine vaping products as a Pharmacist-Only medicine or dispensing them on prescription from a doctor or nurse practitioner," Morris said.
The guidelines also outline requirements for patient consultations, clinical assessments, documentation, and obtaining informed consent.
These measures ensure compliance with jurisdictional legislation while meeting patient needs.
The development of the guidelines was funded by the Australian Government Department of Health and involved expert review and stakeholder input.
PSA has also scheduled a series of workshops to provide additional support in managing nicotine dependence under the new government regulations.
For those interested in accessing the guidelines, and registering for upcoming events, CLICK HERE. JG
The above article was sent to subscribers in Pharmacy Daily's issue from 27 Sep 24
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 27 Sep 24
